Last reviewed · How we verify
Calendula
At a glance
| Generic name | Calendula |
|---|---|
| Sponsor | Stratpharma AG |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Muscular Pain
- Joint Pain
- Back Pain
- Nerve Pain
- Arthritis Pain
Common side effects
Key clinical trials
- Mobile Peer Support for OUD Recovery (NA)
- Studying Glucose and Appetite Response With Alternatives to Soda Pop (NA)
- Improving Social Connectedness Through Digital Health to Enhance Recovery from OUD Among the Justice Involved Population (NA)
- Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy (NA)
- Investigating the Acute and Chronic Effects of a Supplement Containing Caffeine, Vitamins, Minerals and Botanical Extracts on Cognition, Sleep and Wellbeing, in Healthy Volunteers (NA)
- Efficacy of Twinkle Eyez Supplementation in Improving Ocular Health and Immunity (NA)
- StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients (NA)
- The Effect of Oral Sprays on Salivary pH (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calendula CI brief — competitive landscape report
- Calendula updates RSS · CI watch RSS
- Stratpharma AG portfolio CI